ClinConnect ClinConnect Logo

Main Menu

Search for Trials
Browse by Condition
For Industry
Blog
Contact Us
Dark Mode
Log in Sign up

Clinical Trials in Malaga, Andalucia

Find clinical trials in Malaga, Andalucia. Discover local research opportunities and treatment options in your area.

16 Active Trials Found in Malaga

Showing 16 trials on this page

Page 1 of 1

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Participants With Follicular Lymphoma

NCT ID: NCT06091254

This clinical trial is studying a new experimental drug called odronextamab to see if it is safe and effective for people with follicular lymphoma, a type of blood cancer. The trial has two parts: ...

Recruiting
Phase: PHASE3 Conditions: Follicular Lymphoma (FL)

Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine

NCT ID: NCT06543914

This clinical trial is studying the effectiveness of a medication called atogepant for treating migraines in adults. Migraines are severe headaches that can come with symptoms like nausea and sensi...

Recruiting
Conditions: Migraine

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

NCT ID: NCT03486873

This clinical trial, called MK-3475-587, is looking into the long-term safety and effectiveness of a treatment called pembrolizumab (also known as MK-3475) for patients with advanced tumors. If you...

Recruiting
Phase: PHASE3 Conditions: Solid Tumors, Hematologic Malignancies

Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes

NCT ID: NCT06008756

The CORALreef study is a clinical trial that is looking at a new medication called enlicitide decanoate, which is an oral treatment designed to help lower cholesterol and reduce the risk of serious...

Recruiting
Phase: PHASE3 Conditions: Arteriosclerosis, Hypercholesterolaemia

Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension

NCT ID: NCT06492291

This clinical trial, called the CORALreef Extension, is studying a medication called enlicitide decanoate in adults who have high cholesterol, also known as hypercholesterolemia. It is an extension...

Recruiting
Phase: PHASE3 Conditions: Hypercholesterolemia

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

NCT ID: NCT06597019

This clinical trial is studying a medication called inclisiran to see how safe and effective it is for children aged 6 to under 12 years who have a condition known as heterozygous familial hypercho...

Recruiting
Phase: PHASE3 Conditions: Familial Hypercholesterolemia - Heterozygous

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

NCT ID: NCT06637423

This clinical trial is studying a new treatment called Sacituzumab Tirumotecan (MK-2870) for patients with a type of bladder cancer known as non-muscle invasive bladder cancer (NMIBC). The main goa...

Recruiting
Phase: PHASE1 Conditions: Non-Muscle Invasive Bladder Cancer

Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab After Marketing Approval in Spain

NCT ID: NCT07013760

This clinical trial is looking to understand how effective a medication called tezepelumab is in treating patients with severe asthma in Spain. The study will gather information from patients who h...

Not yet recruiting
Conditions: Asthma

Secukinumab Open Label Roll-over Extension Protocol

NCT ID: NCT04638647

The Secukinumab Open Label Roll-over Extension Protocol is a clinical trial that aims to understand the long-term safety of a medication called secukinumab for people with autoimmune and inflammato...

Recruiting
Phase: PHASE4 Conditions: Autoimmunity, Inflammation

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

NCT ID: NCT05147220

This clinical trial is investigating the effectiveness and safety of a new medication called remibrutinib compared to an existing treatment, teriflunomide, for people with relapsing multiple sclero...

Recruiting
Phase: PHASE3 Conditions: Relapsing Multiple Sclerosis

A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab

NCT ID: NCT05142696

This clinical trial is studying a new treatment approach for patients with extensive stage small cell lung cancer (ES-SCLC), which is a type of aggressive lung cancer. The researchers want to find ...

Recruiting
Phase: PHASE1 Conditions: Extensive Stage Small Cell Lung Cancer

A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma

NCT ID: NCT05562466

This clinical trial is looking at a new treatment called QMF149, which combines two medications, indacaterol and mometasone, to see if it works better than another medication called budesonide for ...

Recruiting
Phase: PHASE3 Conditions: Asthma

Observational Cross-reactivity Study for Colorectal Cancer Diagnosis

NCT ID: NCT06889844

This clinical trial is studying a blood test designed to help diagnose colorectal cancer. The main goal is to find out how often this test might incorrectly suggest that someone has cancer when the...

Recruiting
Conditions: Colorectal Cancer

Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.

NCT ID: NCT04817618

This clinical trial is studying a medication called iptacopan (LNP023) to see how effective and safe it is for patients with a kidney disease known as C3 glomerulopathy (C3G). The trial is currentl...

Recruiting
Phase: PHASE3 Conditions: C3G

An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) in Routine Clinical Practice Settings in Europe

NCT ID: NCT05363319

This clinical trial is studying the effectiveness and safety of a medication called cemiplimab (also known as Libtayo®) for adults with advanced non-small cell lung cancer (NSCLC). The researchers ...

Recruiting
Conditions: Non-small Cell Lung Cancer

A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

NCT ID: NCT06470048

This clinical trial is studying a medication called ianalumab to see how well it works, how safe it is, and how well people tolerate it in patients with a condition called diffuse cutaneous systemi...

Recruiting
Phase: PHASE2 Conditions: Diffuse Cutaneous Systemic Sclerosis
Search All Trials Browse All Locations